MKI67 and breast carcinoma: The joint detection of Topo IIα and Ki67 is beneficial to the prognosis determination of breast cancer and the selection of postoperative therapeutic regimen, and the coexpression of Topo IIα and Ki67 can be used for predicting chemotherapeutic efficacy.